WHO sounds its alarms over the rapid spread of the Omicron variant

The Omicron variant of coronavirus it is spreading faster than the Delta variant and is causing infections in people already vaccinated or who have recovered from the disease COVID-19, said the World Health Organization (who).

WHO chief scientist Soumya Swaminathan said Monday that it would be “unwise” to conclude from early tests that Omicron is a milder variant than previous ones. Soumya Swaminathan told Geneva-based reporters that “with increasing numbers, all health systems will be under pressure.”

He cautioned that South Africa and other places that reported lower rates of hospitalization for Omicron had been hit hard in previous waves, so many of the Omicron cases may have been reinfections. “The variant may behave differently in people with prior immunity,” he said.

What did the WHO say about the Omicron variant?

OMS is sounding its alarms over the rapid spread of the Omicron variant.

“The variant is successfully evading some immune responses, he said, which means that the booster programs being implemented in many countries should be aimed at people with weaker immune systems.

“There is now consistent evidence that Omicron is spreading significantly faster than the Delta variant,” WHO Director-General Tedros Adhanom Ghebreyesus said at the briefing. “And people vaccinated or recovered from COVID-19 are more likely to become infected or reinfected,” Tedros said.

His comments echoed the finding of a study from Imperial College London, which said last week that the risk of reinfection was more than five times higher and has shown no evidence of being milder than Delta.

But while antibody defenses for some actions have been undermined, there is hope that T cells, the second pillar of an immune response, can prevent serious disease by attacking infected human cells.

Little is known about the handling of Omicron

OMS is sounding its alarms over the rapid spread of the Omicron variant.

WHO expert Abdi Mahamud added: “Although we are seeing a reduction in neutralizing antibodies, almost all preliminary analyzes show that T-cell-mediated immunity remains intact, that’s what we really need.”

However, highlighting how little is known about how to handle the new variant that was detected last month, Swaminathan also said: “Of course there is a challenge, many of the monoclonals will not work with Omicron.”

He did not elaborate, as he referred to treatments that mimic natural antibodies to fight infection. AmericanPost.News reports that some drug companies have suggested the same.

Follow us on Google News, Facebook and Twitter to stay informed.